Currently holds positions in IDEXX Laboratories Inc and GlycoMimetics Inc
Position | Company | Period |
---|---|---|
Independent Director | IDEXX Laboratories Inc | March 11, 2014 - |
Independent Director | GlycoMimetics Inc | March 17, 2016 - |
Independent Director | Vitae Pharmaceuticals LLC | July 27, 2016 - Oct. 25, 2016 |
President, Chief Executive Officer, Director | ImmunoGen Inc | Dec. 30, 2013 - May 16, 2016 |
President, Chief Executive Officer, Interim Chief Financial Officer, Director | ImmunoGen Inc | Sept. 13, 2013 - Dec. 30, 2013 |
President, Chief Executive Officer, Director | ImmunoGen Inc | Jan. 1, 2009 - Sept. 13, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-05-10 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
30,000
+47.4%
1.5646,800 USD |
30,000 +47.4% | 1.56 | 46,800 USD | |
2023-02-17 | 2023-02-16 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
2,187
-42.3%
511.681,119,044 USD |
2,187 -42.3% | 511.68 | 1,119,044 USD | |
2022-12-07 | 2022-12-05 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
3,046
-50.6%
424.911,294,276 USD |
3,046 -50.6% | 424.91 | 1,294,276 USD | |
2022-11-18 | 2022-11-17 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
20,000
+46.2%
1.8737,400 USD |
20,000 +46.2% | 1.87 | 37,400 USD | |
2021-05-24 | 2021-05-21 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
2,500
-46.4%
539.571,348,918 USD |
2,500 -46.4% | 539.57 | 1,348,918 USD | |
2021-02-24 | 2021-02-22 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
1,888
-39.6%
538.571,016,815 USD |
1,888 -39.6% | 538.57 | 1,016,815 USD | |
2021-02-24 | 2021-02-22 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
10
-0.2%
539.195,392 USD |
10 -0.2% | 539.19 | 5,392 USD | |
2020-08-21 | 2020-08-20 |
IDEXX Laboratories Inc
(IDXX)
|
S Sale |
3,722
-56.7%
382.611,424,063 USD |
3,722 -56.7% | 382.61 | 1,424,063 USD | |
2020-03-10 | 2020-03-09 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
20,000
+111.1%
3.4068,000 USD |
20,000 +111.1% | 3.40 | 68,000 USD | |
2019-08-15 | 2019-08-13 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
10,000
+125.0%
3.1831,800 USD |
10,000 +125.0% | 3.18 | 31,800 USD | |
2016-12-21 | 2016-12-20 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
5,000
+inf%
6.0130,050 USD |
5,000 +inf% | 6.01 | 30,050 USD |